June 18, 2012 — Epicardial ablation device maker Contact Inc. announced that new long-term physician data demonstrated promising clinical outcomes for the multidisciplinary convergent procedure in the treatment of persistent atrial fibrillation (AF), with more than 80 percent of patients remaining in sinus rhythm at a minimum of 12 months follow-up. The data was presented by physicians at Heart Rhythm 2012, the Heart Rhythm Society's 33rd Annual Scientific Sessions in May. 

 

June 18, 2012 — Toshiba America Medical Systems, Inc. will showcase the Aplio 500, Aplio 300 and Viamo ultrasound systems at the Society for Vascular Ultrasound (SVU) annual conference, June 7 to June 9, 2012, in National Harbor, Md. All systems combine advanced visualization capabilities with ergonomics and flexibility to improve departmental efficiency.

June 18, 2012 — St. Jude Medical Inc. announced it has received U.S. Food and Drug Administration (FDA) clearance and will immediately launch the Amplatzer Vascular Plug 4 (AVP 4) for use in transcatheter embolization procedures (minimally invasive procedures that involve the selective blocking of blood vessels) within the peripheral vasculature.

 

June 18, 2012 — Endosense announced its TactiCath Quartz force-sensing ablation catheter has been CE mark approved for use in Europe. In cooperation with the company’s distributor Biotronik, first cases using the new device have been performed by renowned physicians at three centers across Europe.

June 18, 2012 — United Health Services (UHS), a locally owned, not-for-profit, 916-bed hospital and healthcare system serving the greater Binghamton, N.Y. area has selected Philips Live 3-D transesophageal echo (TEE) technology for cardiac care, marking the system’s 2,500th installation in North America.

June 15, 2012 — Boston Scientific Corp. has initiated use of the LATITUDE NXT Remote Patient Management System with patients in Europe.

June 15, 2012 —Vascular Solutions Inc. today announced that it has acquired the radial artery access wrist positioning splint product assets of privately-held Accumed Systems Inc.

June 15, 2012 —Endosense, a pioneer and leader in force-sensing technology focused on improving the efficacy and safety of catheter ablation for the treatment of cardiac arrhythmias, has announced enrollment completion in the TOCCASTAR clinical study.

GE Healthcare introduced the latest addition to its Nuclear Medicine 600 series with a new performance SPECT/CT (single photon emission computed tomography/computed tomography) system, the Optima NM/CT 640.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now